Unichem Laboratories Limited (UNICHEMLAB.NS)
INR 570.85
(2.58%)
INR 570.85
(2.58%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 4.86 Billion INR | -32.59% |
| 2022 | 7.92 Billion INR | -1.9% |
| 2021 | 8.07 Billion INR | 2.4% |
| 2020 | 7.88 Billion INR | 5.55% |
| 2019 | 7.47 Billion INR | 13.97% |
| 2018 | 6.55 Billion INR | 61.25% |
| 2017 | 4.06 Billion INR | -58.97% |
| 2016 | 9.9 Billion INR | 14.55% |
| 2015 | 8.64 Billion INR | 14.93% |
| 2014 | 7.52 Billion INR | 1.91% |
| 2013 | 7.38 Billion INR | 7.68% |
| 2012 | 6.85 Billion INR | 32.1% |
| 2011 | 5.19 Billion INR | -36.99% |
| 2010 | 8.24 Billion INR | 10.26% |
| 2009 | 7.47 Billion INR | 1.65% |
| 2008 | 7.35 Billion INR | 9.52% |
| 2007 | 6.71 Billion INR | 6.91% |
| 2006 | 6.27 Billion INR | 14.74% |
| 2005 | 5.47 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1.59 Billion INR | 15.05% |
| 2023 FY | 5.33 Billion INR | -32.59% |
| 2023 Q1 | 2.54 Billion INR | 11.36% |
| 2023 Q2 | 2.52 Billion INR | -0.75% |
| 2023 Q3 | 2.67 Billion INR | 5.96% |
| 2023 Q4 | 1.38 Billion INR | -48.4% |
| 2022 Q4 | 2.28 Billion INR | 38.91% |
| 2022 FY | 7.92 Billion INR | -1.9% |
| 2022 Q3 | 1.64 Billion INR | -17.37% |
| 2022 Q2 | 1.99 Billion INR | -0.02% |
| 2022 Q1 | 1.99 Billion INR | -11.43% |
| 2021 FY | 8.07 Billion INR | 2.4% |
| 2021 Q1 | 1.87 Billion INR | 27.38% |
| 2021 Q4 | 2.25 Billion INR | 11.42% |
| 2021 Q2 | 1.92 Billion INR | 2.81% |
| 2021 Q3 | 2.01 Billion INR | 4.76% |
| 2020 Q4 | 1.47 Billion INR | -33.85% |
| 2020 FY | 7.88 Billion INR | 5.55% |
| 2020 Q3 | 2.22 Billion INR | 1.54% |
| 2020 Q2 | 2.19 Billion INR | 15.41% |
| 2020 Q1 | 1.89 Billion INR | 23.93% |
| 2019 Q3 | 2.07 Billion INR | 8.65% |
| 2019 Q2 | 1.9 Billion INR | -2.3% |
| 2019 FY | 7.47 Billion INR | 13.97% |
| 2019 Q1 | 1.95 Billion INR | 6.05% |
| 2019 Q4 | 1.53 Billion INR | -26.12% |
| 2018 FY | 6.55 Billion INR | 61.25% |
| 2018 Q1 | 1.37 Billion INR | 63.12% |
| 2018 Q4 | 1.84 Billion INR | -6.82% |
| 2018 Q3 | 1.97 Billion INR | 45.85% |
| 2018 Q2 | 1.35 Billion INR | -1.65% |
| 2017 Q4 | 845.15 Million INR | 0.0% |
| 2017 FY | 4.06 Billion INR | -58.97% |
| 2016 Q4 | 6.71 Billion INR | 0.0% |
| 2016 FY | 9.9 Billion INR | 14.55% |
| 2015 FY | 8.64 Billion INR | 14.93% |
| 2014 FY | 7.52 Billion INR | 1.91% |
| 2013 FY | 7.38 Billion INR | 7.68% |
| 2012 FY | 6.85 Billion INR | 32.1% |
| 2011 FY | 5.19 Billion INR | -36.99% |
| 2010 FY | 8.24 Billion INR | 10.26% |
| 2009 FY | 7.47 Billion INR | 1.65% |
| 2008 FY | 7.35 Billion INR | 9.52% |
| 2007 FY | 6.71 Billion INR | 6.91% |
| 2006 FY | 6.27 Billion INR | 14.74% |
| 2005 FY | 5.47 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 81.834% |
| Hester Biosciences Limited | 1.27 Billion INR | -281.968% |
| Aarti Drugs Limited | 8.31 Billion INR | 41.501% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | 16.573% |
| Albert David Limited | 1.4 Billion INR | -245.499% |
| Alembic Limited | 1 Billion INR | -386.441% |
| Alkem Laboratories Limited | 52.29 Billion INR | 90.697% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | -975.948% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -230.542% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -38679.841% |
| Brooks Laboratories Limited | 65.62 Million INR | -7313.793% |
| Eris Lifesciences Limited | 10.42 Billion INR | 53.342% |
| FDC Limited | 6.58 Billion INR | 26.135% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 60.871% |
| Gufic Biosciences Limited | 4.07 Billion INR | -19.422% |
| Hikal Limited | 5.95 Billion INR | 18.346% |
| Ind-Swift Limited | 2.17 Billion INR | -123.929% |
| Innova Captab Limited | 3.46 Billion INR | -40.425% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | -3.09% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -645.48% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 75.233% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | -157.831% |
| Lupin Limited | 125.09 Billion INR | 96.111% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | -603.846% |
| Medico Remedies Limited | 262.14 Million INR | -1755.824% |
| Morepen Laboratories Limited | 6.16 Billion INR | 21.04% |
| Nectar Lifesciences Limited | 4.82 Billion INR | -0.863% |
| Orchid Pharma Limited | 2.32 Billion INR | -109.668% |
| Procter & Gamble Health Limited | 5.78 Billion INR | 15.852% |
| RPG Life Sciences Limited | 2.48 Billion INR | -95.93% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -684.063% |
| Sigachi Industries Limited | 2 Billion INR | -142.969% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 393.794% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -17.987% |
| Themis Medicare Limited | 2.42 Billion INR | -101.03% |
| Vaishali Pharma Limited | 90.32 Million INR | -5286.149% |
| Wanbury Limited | 1.73 Billion INR | -181.105% |
| Windlas Biotech Limited | 1.33 Billion INR | -263.38% |
| ZIM Laboratories Limited | 1.26 Billion INR | -283.726% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | -17.703% |
| Ipca Laboratories Limited | 48.58 Billion INR | 89.987% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 98.118% |
| Venus Remedies Limited | 2.18 Billion INR | -122.898% |
| Sakar Healthcare Limited | 699.58 Million INR | -595.402% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 95.559% |
| Divi's Laboratories Limited | 32.44 Billion INR | 85.003% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | 21.82% |
| Mankind Pharma Limited | 42.19 Billion INR | 88.471% |
| Sequent Scientific Limited | 2.97 Billion INR | -63.322% |
| Laurus Labs Limited | 15.44 Billion INR | 68.509% |
| Neuland Laboratories Limited | 8.24 Billion INR | 41.016% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | 68.117% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 92.984% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 96.115% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -132.323% |
| Wockhardt Limited | 7.72 Billion INR | 36.983% |
| Bal Pharma Limited | 770.19 Million INR | -531.649% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 97.026% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -31.647% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | -819.41% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | 47.158% |
| Shilpa Medicare Limited | 3.56 Billion INR | -36.583% |
| Valiant Laboratories Limited | 138.02 Million INR | -3424.572% |
| Ajanta Pharma Limited | 21.06 Billion INR | 76.904% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -4204.144% |
| Granules India Limited | 16.79 Billion INR | 71.041% |
| Medicamen Biotech Limited | 495.49 Million INR | -881.833% |
| Syncom Formulations (India) Limited | 559.5 Million INR | -769.509% |
| Piramal Enterprises Limited | 8.04 Billion INR | 39.516% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 89.595% |
| NATCO Pharma Limited | 25.73 Billion INR | 81.097% |
| Suven Life Sciences Limited | -200.79 Million INR | 2522.811% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 4573.623% |
| Strides Pharma Science Limited | 14.38 Billion INR | 66.188% |
| Indoco Remedies Limited | 8.04 Billion INR | 39.513% |
| Alpa Laboratories Limited | 188.89 Million INR | -2475.468% |
| Lasa Supergenerics Limited | 121.02 Million INR | -3919.608% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | -1144.018% |